Moleculin Biotech, Inc. MBRX

Jonathan Foster, executive vice president and chief financial officer of Moleculin, stated, "We finished the third quarter with a solid balance sheet with cash of approximately $15.4 million and no debt. We believe our existing cash and cash equivalents will be sufficient to fund our planned operations well into the second quarter of 2020 without the issuance of additional equity for cash.

Mbrx
Jonathan Foster, executive vice president and chief financial officer of Moleculin, stated, "We finished the third quarter with a solid balance sheet with cash of approximately $15.4 million and no debt. We believe our existing cash and cash equivalents will be sufficient to fund our planned operations well into the second quarter of 2020 without the issuance of additional equity for cash.

Mbrx Soon 1$

Tavis wishes she could get back in but too scared. Dumbass

Useless posts by Sumaera again!!! Not surprising.

Short sale volume yesterday down to 13%, lowest in past few weeks

High hope

PM someone trying to short, 500 shares drops it 10 cents. What manipulation. Think it’s time for the shorts to start running

Short sale 22-35% past week and this stock goes down. Someone definitely wants it to stay down even though has good institutional buying, positive earnings and strong pipeline.

Manipulated price for sure